Health ❯ Healthcare ❯ Clinical Trials

Cancer Research

Immunotherapy Lung Cancer Glioblastoma Survival Rates Prostate Cancer Personalized Medicine Breast Cancer Multiple Myeloma Melanoma Trials Therapeutic Innovations

UCSF-Led Study Engineers CAR-T Cells In Vivo, Clearing Tumors in Mice

Researchers say the preclinical method now requires scaling followed by human trials.

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

Trials Show Fecal Transplants Enhance Cancer Immunotherapy, Including Longer PFS in Randomized Kidney Study

Epcoritamab Improves PFS but Not OS in Phase 3 DLBCL Trial

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

City of Hope Completes $1.5 Billion Irvine Cancer Hospital, First Patients Arrive Dec. 1

Small Pediatric Study Links Pazopanib to Improved Two-Year Survival in Metastatic Ewing Sarcoma

Pluvicto Added to Standard Care Extends rPFS in PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

STAT3 Decoy Shows Early Promise in First Cat Cancer Trial, Pointing Toward Human Studies

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Russia to Begin Patient Doses of Personalized mRNA Cancer Vaccine in Coming Months

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Dual-Species Bacterial Therapy Destroys Tumors Without Immune Cells